Emtherapro

Decatur, United States

Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.

$3.0M raised

Sep 2023

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Emtherapro

How much funding has Emtherapro raised?

Emtherapro has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Where is Emtherapro headquartered?

Emtherapro is headquartered in Decatur, United States.

What does Emtherapro do?

Emtherapro is a biotech company that offers precision medicine enablement solutions for neurogenetic disorders.

What stage is Emtherapro at?

Emtherapro is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 7, 2023.

MLA

"Emtherapro — Funding & Investors." VCBacked, September 7, 2023, https://www.vcbacked.co/company/emtherapro. Accessed July 1, 2026.

APA

VCBacked. (2023). Emtherapro — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/emtherapro

Wikipedia (cite web)

{{cite web |title=Emtherapro — Funding & Investors |url=https://www.vcbacked.co/company/emtherapro |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 7, 2023.